Cargando…
Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review
OBJECTIVE: The emerging renal complications in beta-thalassemia patients have raised the global exchange of views. Despite better survival due to blood transfusion and iron chelation therapy, the previously unrecognized renal complication remain a burden of disease affecting this population —the pri...
Autores principales: | Romadhon, Pradana Zaky, Ashariati, Ami, Bintoro, Siprianus Ugroseno Yudho, Thaha, Mochammad, Suryantoro, Satriyo Dwi, Windradi, Choirina, Mahdi, Bagus Aulia, Novendrianto, Dwiki, Widiyastuti, Krisnina Nurul, Martani, Okla Sekar, Widiasi, Etha Dini, Agustin, Esthiningrum Dewi, Prabowo, Emil, Putra, Yasjudan Rastrama, Thahadian, Harik Firman, Adhikara, Imam Manggalya, Adyarini, Dwita Dyah, Prahasanti, Kartika, Putri, Aditea Etnawati, Yusoff, Narazah Mohd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717586/ https://www.ncbi.nlm.nih.gov/pubmed/36467279 http://dx.doi.org/10.2147/JBM.S387416 |
Ejemplares similares
-
Case Report: Priapism as The Clinical Presenting Feature of Chronic Myeloid Leukemia: Case Report and 20-Year Literature Review
por: Bintoro, Siprianus Ugroseno Yudho, et al.
Publicado: (2022) -
Prognosticating 2-Year Survival Rate of Breast Cancer Patients Through Plasma miRNA-21 and Other Associating Factors
por: Romadhon, Pradana Zaky, et al.
Publicado: (2022) -
How to prioritize treatment in dual malignancy: A case report of patient with non-Hodgkin lymphoma and breast cancer
por: Chomariyati, Alvi, et al.
Publicado: (2022) -
Hematologic and coagulopathy parameter as a survival predictor among moderate to severe COVID-19 patients in non- ICU ward: a single-center study at the main referral hospital in Surabaya, East Java, Indonesia
por: Bintoro, Siprianus Ugroseno Yudho, et al.
Publicado: (2021) -
Early detection breast cancer: role of circulating plasma miRNA-21 expression as a potential screening biomarker
por: DIANSYAH, Muhammad Noor, et al.
Publicado: (2021)